Statin: Clinical Trials

14 trials of Statin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 4 unknown, 2 terminated. 14 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 8, Unknown 4, Terminated 2
Phase 23Unknown 3

Follow Statin: new trials by email Literature Review of Statin trials Research Report on Statin

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
Statin - Intracerebral Hemorrhage, Statins
Phase 2 / Phase 3UnknownCapital Medical University982021-08-062024-01-23
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/ unfractionated heparin, Atorvastatin 20mg - Covid19
Phase 3CompletedRajaie Cardiovascular Medical and Research Center6002020-07-302021-08-17
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
DLBS1033, Aspirin, Statin - Ischemic Stroke
Phase 2 / Phase 3UnknownDuta Wacana Christian University1802020-04-012020-06-11
Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin
Aspirin, Atorvastatin, Placebo Aspirin - Acute Chest Syndrome
Phase 3TerminatedDr. med. Mahir Karakas682020-02-212022-05-24
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Gefarnate, Statin - Coronary Artery Disease
Phase 2 / Phase 3UnknownFirst Affiliated Hospital of Harbin Medical University702019-09-012020-07-30
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease
Phase 3UnknownAlfa Wassermann Tunisia1562019-01-312019-12-02
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Statin, Atorvastatin, Placebo - Carotid Artery Stenosis, Strokes
Phase 3TerminatedColumbia University312017-06-012026-05-07
Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy
Vitamin D, Simvastatin, Placebo - Dyslipidemias
Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh332013-12-012017-03-31
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
Placebo (for alirocumab), Alirocumab, Statin - Hypercholesterolemia
Phase 3CompletedRegeneron Pharmaceuticals8032013-09-012017-03-21
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Statin, ACE inhibitor, Placebo - Type 1 Diabetes
Phase 3CompletedUniversity of Cambridge4432009-01-012018-06-28
Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
Statin - Ischemic Stroke
Phase 3CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan8542004-03-012016-04-25
hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)
Statin - Ischemic Stroke
Phase 3CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan10952004-03-012016-04-25
Intima Media Thickness Regression in Dyslipidemic Teenagers
Atorvastatin, sugar pill - Obesity, Dyslipidemia
Phase 3CompletedUniversité de Montréal162004-01-012013-01-15
A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)
Ezetimibe, Placebo, Simivastatin - Primary Hypercholesterolemia
Phase 3CompletedOrganon and Co7692001-01-312024-05-10

Conditions studied

Stroke (4)  ·  Hypercholesterolemia (3)  ·  Ischemic Stroke (3)  ·  Brain Ischemia (2)  ·  Dyslipidemias (2)  ·  Hyperlipidemias (2)  ·  Recurrence (2)  ·  Acute Chest Syndrome (1)  ·  COVID-19 (1)  ·  Carotid Stenosis (1)  ·  Cerebral Hemorrhage (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Motor Activity (1)  ·  Obesity (1)

Sponsors

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (2)  ·  Alfa Wassermann Tunisia (1)  ·  Capital Medical University (1)  ·  Columbia University (1)  ·  Dr. med. Mahir Karakas (1)  ·  Duta Wacana Christian University (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Organon and Co (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Rajaie Cardiovascular Medical and Research Center (1)  ·  Regeneron Pharmaceuticals (1)  ·  University of Cambridge (1)  ·  Université de Montréal (1)

Countries

Canada (3)  ·  China (2)  ·  Japan (2)  ·  United States (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Indonesia (1)  ·  Iran (1)  ·  Israel (1)  ·  Norway (1)  ·  Slovakia (1)  ·  Tunisia (1)

Top investigators

Masayasu Matsumoto, MD, PhD (2)  ·  Anil Bhansali, DM (1)  ·  Behnood Bikdeli, MD, MS (1)  ·  David B Dunger, Professor (1)  ·  Edward S Connolly, MD, FACS (1)  ·  Eric Heyer, MD, Ph.D. (1)  ·  Imed Frikha, MD (1)  ·  Laurent Legault, MD (1)  ·  Mahir Karakas, MD (1)  ·  Parham Sadeghipour, MD (1)  ·  Rizaldy Pinzon, MD, MSc, PhD (1)

Results publications

PMID 12423708, PMID 15811480, PMID 22416821, PMID 25392936, PMID 27639753, PMID 29091568, PMID 29191850, PMID 31035902, PMID 31166599, PMID 32108022, PMID 32928709, PMID 32992075, PMID 33100044, PMID 33734299, PMID 34996756, PMID 35165110, PMID 35244208, PMID 36944357, PMID 38124088, PMID 38908848, PMID 39673820, PMID 42056188, PMID 42718842